Paxman’s Clinical Pioneer Programme
British scalp cooling pioneer, Paxman has announced the dates of its first ever ‘Clinical Pioneer Programme (CPP)’ with workshops taking place in 5 UK cities.
The certified initiative offers individuals within chemotherapy units to be certified as a scalp cooling expert and enables them to remain up-to-date with the latest information.
Locations include Manchester, Edinburgh, Birmingham, London and Reading and will take place during May and June. More dates will be announced later in the year.
The Paxman Cooling System (also known as the ‘cold cap’) alleviates the damage caused to the hair follicles by chemotherapy. It works by reducing the temperature of the scalp by a few degrees immediately before, during and after the administration of chemotherapy.
Through the accreditation, clinicians will be given the knowledge, confidence and authority to become a scalp cooling expert and offer advice to other clinicians if they are not using the system correctly.
In turn, this will enable the provision of additional support within the unit, and enhance best practice and use of all of scalp cooling systems. It will also provide achievable quality standards, supportive consultancy and benchmarking to help improve the quality of care that patients receive.
Paxman has over 1,000 cooling systems in 95% of hospitals in the UK providing scalp cooling treatment for cancer patients. Despite the large amount of scalp cooling machines available, the public’s awareness is extremely low.
Claire Paxman, Director of Sales and Training, said “We are extremely excited to launch our accredited clinical programmes and to be able to announce our first five dates in the UK.
“It is believed that only 10% of the public know what scalp cooling is, while 8% of patients refuse chemotherapy because they do not want to lose their hair. There are also several misconceptions about what the treatment is, from both nurses and patients. We are desperate to change this and are working hard to ensure that our machines are being used effectively and that chemotherapy units understand exactly what scalp cooling is.”
The Clinical Pioneer Programme is part of Paxman’s ‘Changing the Face of Cancer’ campaign and will be rolled out in the UK first, with a view to expand in other markets in the future.
For more information visit www.paxmanscalpcooling.com